Home › Epilepsy

Epilepsy clinical trials recruiting in the U.S.

101 studies for Epilepsy are recruiting participants at sites across the United States.

Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.

Cities with the most studies

• Boston, MA20 studies
• Houston, TX16 studies
• New York City, NY14 studies
• Washington, DC13 studies
• Philadelphia, PA12 studies
• Phoenix, AZ10 studies
• Cleveland, OH9 studies
• Mountain View, CA8 studies
• Rochester, MN8 studies
• St. Louis, MO8 studies
• Miami, FL8 studies
• Durham, NC8 studies
• Cincinnati, OH7 studies
• Jacksonville, FL7 studies
• Birmingham, AL7 studies
• Nashville, TN7 studies
• Los Angeles, CA7 studies
• Chicago, IL6 studies
• Aurora, CO6 studies
• Charlotte, NC5 studies
• Columbus, OH5 studies
• Dallas, TX5 studies
• Clifton, NJ5 studies
• Boise, ID5 studies
• Pittsburgh, PA5 studies
• Ann Arbor, MI4 studies
• Tampa, FL4 studies
• New Haven, CT4 studies
• Minneapolis, MN4 studies
• Little Rock, AR4 studies
• Orange, CA4 studies
• Detroit, MI4 studies
• Baltimore, MD4 studies
• Akron, OH4 studies
• Tucson, AZ4 studies
• San Diego, CA4 studies
• Salt Lake City, UT4 studies
• Sacramento, CA3 studies
• Portland, OR3 studies
• Kansas City, KS3 studies

By state

• Alabama9 studies
• Arizona11 studies
• Arkansas5 studies
• California21 studies
• Colorado7 studies
• Connecticut4 studies
• Florida14 studies
• Georgia5 studies
• Idaho5 studies
• Illinois8 studies
• Kansas3 studies
• Kentucky3 studies
• Maryland16 studies
• Massachusetts23 studies
• Michigan9 studies
• Minnesota11 studies
• Missouri9 studies
• New Hampshire6 studies
• New Jersey5 studies
• New York18 studies
• North Carolina12 studies
• Ohio19 studies
• Oregon3 studies
• Pennsylvania14 studies
• Tennessee8 studies
• Texas22 studies
• Utah4 studies
• Virginia4 studies
• Washington3 studies
• Wisconsin3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.